Sharenet Sites 
Sharenet Sites
Trading statement – Unaudited interim group results for the six months ended 30 September 2014
MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
(Share code: MDC)
(ISIN: ZAE000074142)
("Mediclinic" or “the Company”)
TRADING STATEMENT – UNAUDITED INTERIM GROUP RESULTS FOR THE SIX
MONTHS ENDED 30 SEPTEMBER 2014
In terms of the JSE Limited (“JSE”) Listings Requirements,
companies are required to publish a trading statement as soon as
they are satisfied that a reasonable degree of certainty exists
that the financial results for the period to be reported upon next
will differ by at least 20% from that of the previous
corresponding reporting period. Mediclinic is in the process of
finalising its interim results for the six months ended 30
September 2014, which are due to be released on SENS on 6 November
2014 and published in the press on 7 November 2014 (“interim
results announcement”).
Accordingly, shareholders are advised that for the six months
ended 30 September 2014:
- basic earnings per share (“EPS”) are expected to be between 21
and 38 cents, or between 12% and 22% higher than the 173.5 cents
reported for the six months ended 30 September 2013; and
- basic headline earnings per share (“HEPS”), which exclude the
effects of capital transactions, are expected to be between 7 and
24 cents, or between 4% and 14% higher than the 173.2 cents
reported for the six months ended 30 September 2013.
In order to provide clear and meaningful guidance to shareholders,
this trading statement also addresses normalised HEPS. Normalised
HEPS are defined as reportable HEPS in terms of accounting
standards, excluding one-off items.
The one-off items are included in calculating the EPS and HEPS
ranges. Details of the one-off items will be provided in the
interim results announcement. Excluding the one-off items, the
basic normalised HEPS for the six months ended 30 September 2014
are expected to be between 26 and 41 cents, or between 17% and 27%
higher than the 152.0 cents reported for the previous
corresponding reporting period.
The financial information on which this trading statement is based
has not been reviewed and reported on by the Company’s external
auditors.
Stellenbosch
29 October 2014
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 21 809 6500
Fax +27 21 886 4037
Ethics line: 0800 005 316
Website: www.mediclinic.com
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 29/10/2014 11:40:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
